Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc.

NNYSE:PBH
48.00
USD
+1.81
(+3.92%)
3.25EPS
14.07P/E
2.17BMarket Cap
Feb 04Next Earn

Total Valuation

USD

As of September 30, 2026, Prestige Consumer Healthcare Inc. carries a market capitalization of 2.17B, placing it among publicly traded companies globally. Its enterprise value stands at 4.25B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.17B
Enterprise Value4.25B

Important Dates

Prestige Consumer Healthcare Inc.'s next confirmed earnings release is scheduled for February 4, 2027.

Earnings Date2/4/2027

Share Statistics

As of September 30, 2026, Prestige Consumer Healthcare Inc. has 47.37M shares outstanding.

Shares Outstanding47.37M

Valuation Ratios

As of September 30, 2026, Prestige Consumer Healthcare Inc. trades at a trailing price-to-earnings ratio of 14.07. The price-to-sales ratio is 1.87, and the price-to-book ratio stands at 1.12.

PE Ratio14.07
PS Ratio1.87
PB Ratio1.12
P/TBV Ratio-1.03
P/FCF Ratio10.22
P/OCF Ratio9.50

Enterprise Valuation

As of September 30, 2026, Prestige Consumer Healthcare Inc. trades at an EV/EBITDA multiple of 12.97 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.64 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 14.61 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Prestige Consumer Healthcare Inc. trades at an EV/FCF ratio of 16.21, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 4.25B versus a market cap of 2.17B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales3.64
EV / EBITDA12.97
EV / EBIT14.61
EV / FCF16.21

Financial Position

As of September 30, 2026, Prestige Consumer Healthcare Inc. maintains a current ratio of 2.92, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 109.39, indicating elevated leverage, while an interest coverage ratio of 4.96 demonstrates adequate ability to service its debt obligations.

Current Ratio2.92
Quick Ratio1.72
Debt / Equity109.39
Debt / EBITDA6.49
Interest Coverage4.96

Financial Efficiency

USD

Over the twelve months ended September 30, 2026, Prestige Consumer Healthcare Inc. posted a return on equity (ROE) of 8.23, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.16 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 3.80, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.86, useful for judging operating efficiency across full business cycles. The company generates approximately 1.43M in revenue per employee across its workforce of 817.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.28 indicates how many times Prestige Consumer Healthcare Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)8.23
Return on Assets (ROA)3.80
Return on Invested Capital (ROIC)6.16
Return on Capital Employed (ROCE)5.86
Revenue Per Employee1.43M
Employee Count817.50
Inventory Turnover3.28

Taxes

USD

Over the twelve months ended September 30, 2026, Prestige Consumer Healthcare Inc. recorded 57.48M in income tax expense. That works out to an effective tax rate of 27.04, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 212.58M, leaving 155.10M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax57.48M
Effective Tax Rate27.04

Stock Price Statistics

USD

As of the close on November 16, 2026, Prestige Consumer Healthcare Inc.'s stock has declined approximately 20.01% over the past 52 weeks. The 50-day moving average sits at 47.32, while the 200-day moving average is 53.06.

52-Week Price Change-20.01%
50-Day Moving Average47.32
200-Day Moving Average53.06

Income Statement

USD

Over the twelve months ended September 30, 2026, Prestige Consumer Healthcare Inc. generated 1.17B in revenue and converted that into 155.10M in net income, yielding earnings per share of 3.25. EBITDA reached 327.88M, while operating income came in at 291.22M.

Revenue1.17B
Gross Profit612.39M
Operating Income291.22M
Pretax Income212.58M
Net Income155.10M
EBITDA327.88M
EBIT291.22M
Earnings Per Share (EPS)3.25

Balance Sheet

USD

As of September 30, 2026, Prestige Consumer Healthcare Inc. holds 46.52M in cash and equivalents against 2.13B in total debt, resulting in a net debt position of 2.04B. Total book value stands at 1.94B, with working capital of 323.63M providing operational flexibility.

Cash & Cash Equivalents46.52M
Total Debt2.13B
Net Debt2.04B
Equity (Book Value)1.94B
Book Value Per Share41.05
Working Capital323.63M

Cash Flow

USD

Prestige Consumer Healthcare Inc. produced 229.78M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -15.56M in capital expenditures, free cash flow totaled 214.22M - equivalent to 4.50 per share.

Operating Cash Flow229.78M
Capital Expenditures-15.56M
Free Cash Flow214.22M
FCF Per Share4.50

Margins

Over the twelve months ended September 30, 2026, Prestige Consumer Healthcare Inc. posted a gross margin of 52.47, reflecting its pricing power and cost economics. The operating margin of 24.95 and net profit margin of 13.29 provide insight into operational efficiency.

Gross Margin52.47
Operating Margin24.95
Pretax Margin18.21
Profit Margin13.29
EBITDA Margin28.09

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 9.78, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -47.49, meaning Prestige Consumer Healthcare Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-47.49
FCF Yield9.78

Scores

As of September 30, 2026, Prestige Consumer Healthcare Inc. has an Altman Z-Score of 8.11, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score8.11